Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma

Journal of Molecular Medicine

Volumn 89, Issue 8, 2011, Pages 817-827

  Gou, Lantu ^a   Wang, Wei ^a   Tong, Aiping ^a   Yao, Yuqin ^a   Zhou, Yan ^a   Yi, Cheng ^a   Yang, Jinliang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Biomarker; Hepatocellular carcinoma; Proteomics; RhoA

Indexed keywords

MEMBRANE PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; PROTEOMICS; RNA INTERFERENCE; SUCROSE DENSITY GRADIENT CENTRIFUGATION; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; CENTRIFUGATION, DENSITY GRADIENT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; PROTEOMICS; RHOA GTP-BINDING PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 80052498093     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0753-3     Document Type: Article

References (34)

1. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 10072408 10.1056/NEJM199903113401001 1:STN:280:DyaK1M7ls1ensg%3D%3D (Pubitemid 29114292)
2. AA Skolnick 1996 Armed with epidemiologic research, China launches programs to prevent liver cancer J Am Med Assoc 276 1458 1459 10.1001/jama.276.18.1458 1:STN:280:DyaK2s%2FmtVaisg%3D%3D (Pubitemid 26398740)
3. B Levin C Amos 1995 Therapy of unresectable hepatocellular carcinoma N Engl J Med 332 1294 1296 7708076 10.1056/NEJM199505113321910 1:STN:280:DyaK2M3itlegtQ%3D%3D
4. J Bruix JM Llovet 2002 Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 519 524 11870363 10.1053/jhep.2002.32089 (Pubitemid 34183954)
5. KR Kim HE Moon KW Kim 2002 Hypoxia-induced angiogenesis in human hepatocellular carcinoma J Mol Med 80 703 714 12436347 10.1007/s00109-002-0380-0 1:CAS:528:DC%2BD38XoslOrsrg%3D (Pubitemid 35352036)
6. RN Aravalli CJ Steer EN Cressman 2008 Molecular mechanisms of hepatocellular carcinoma Hepatology 48 2047 2063 19003900 10.1002/hep.22580 1:CAS:528:DC%2BD1cXhsFams7%2FM
7. M Branda JR Wands 2006 Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma Hepatology 43 891 902 16628664 10.1002/hep.21196 1:CAS:528:DC%2BD28XkvFGmtrg%3D (Pubitemid 43724611)
8. A Sutton P Nahon D Pessayre P Rufat A Poiré M Ziol D Vidaud N Barget N Ganne-Carrié N Charnaux, et al. 2006 Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis Cancer Res 66 2844 2852 16510607 10.1158/0008-5472.CAN-05-2566 1:CAS:528:DC%2BD28XhvV2gtLY%3D
9. XL Du H Hu DC Lin SH Xia XM Shen Y Zhang ML Luo YB Feng Y Cai X Xu, et al. 2007 Proteomic profiling of proteins dysregulated in Chinese esophageal squamous cell carcinoma J Mol Med 85 863 875 17318615 10.1007/s00109-007-0159-4 1:CAS:528:DC%2BD2sXnsl2gtrg%3D (Pubitemid 47077107)
10. BF Cravatt GM Simon JR Yates 3rd 2007 The biological impact of mass-spectrometry-based proteomics Nature 450 991 1000 18075578 10.1038/nature06525 1:CAS:528:DC%2BD2sXhsVaqtr7E (Pubitemid 350273629)
11. T Kondo S Hirohashi 2006 Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics Nat Protoc 1 2940 2956 17406554 10.1038/nprot.2006.421 1:CAS:528:DC%2BD2sXhtFGjtL7K
12. DJ Shields S Niessen EA Murphy A Mielgo JS Desgrosellier SK Lau LA Barnes J Lesperance M Bouvet D Tarin, et al. 2010 RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia Proc Natl Acad Sci USA 107 2189 2194 20080647 10.1073/pnas.0911646107 1:CAS:528:DC%2BC3cXhvFCiur0%3D
13. L Wang YF Zhu XJ Guo R Huo X Ma M Lin ZM Zhou JH Sha 2005 A two-dimensional electrophoresis reference map of human ovary J Mol Med 83 812 821 16021519 10.1007/s00109-005-0676-y 1:CAS:528:DC%2BD2MXhtVOhur3E (Pubitemid 41407865)
14. MH Han SI Hwang DB Roy DH Lundgren JV Price SS Ousman GH Fernald B Gerlitz WH Robinson SE Baranzini, et al. 2008 Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets Nature 451 1076 1081 18278032 10.1038/nature06559 1:CAS:528:DC%2BD1cXisFWjtrg%3D (Pubitemid 351317445)
15. J Zhou T Zhou R Cao Z Liu J Shen P Chen X Wang S Liang 2006 Evaluation of the application of sodium deoxycholate to proteomic analysis of rat hippocampal plasma membrane J Proteome Res 5 2547 2553 17022626 10.1021/pr060112a 1:CAS:528:DC%2BD28Xps1Giu7s%3D (Pubitemid 44595157)
16. LD Jayanthi DJ Samuvel S Ramamoorthy 2004 Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization J Biol Chem 279 19315 19326 14976208 10.1074/jbc.M311172200 1:CAS:528:DC%2BD2cXjsVKmurc%3D (Pubitemid 38623363)
17. N Chignard L Beretta 2004 Proteomics for hepatocellular carcinoma marker discovery Gastroenterology 127 S120 S125 15508075 10.1053/j.gastro.2004.09.025 1:CAS:528:DC%2BD2cXhtVGmtb%2FK (Pubitemid 39423379)
18. TK Seow RC Liang CK Leow MC Chung 2001 Hepatocellular carcinoma: from bedside to proteomics Proteomics 1 1249 1263 11721636 10.1002/1615-9861(200110) 1:10<1249::AID-PROT1249>3.0.CO;2-1 1:CAS:528:DC%2BD3MXotVehur8%3D
19. R Cao X Li Z Liu X Peng W Hu X Wang P Chen J Xie S Liang 2006 Integration of a two-phase partition method into proteomics research on rat liver plasma membrane proteins J Proteome Res 5 634 642 16512679 10.1021/pr050387a 1:CAS:528:DC%2BD28XhtlOqsLk%3D (Pubitemid 43364104)
20. B Norling E Zak B Andersson H Pakrasi 1998 2D-isolation of pure plasma and thylakoid membranes from the cyanobacterium Synechocystis sp. PCC 6803 FEBS Lett 436 189 192 9781676 10.1016/S0014-5793(98)01123-5 1:CAS:528: DyaK1cXmtl2ns7k%3D (Pubitemid 28468553)
21. MJ Peirce R Wait S Begum J Saklatvala AP Cope 2004 Expression profiling of lymphocyte plasma membrane proteins Mol Cell Proteomics 3 56 65 14573526 1:CAS:528:DC%2BD2cXhtVantL0%3D (Pubitemid 38697104)
22. DN Perkins DJ Pappin DM Creasy JS Cottrell 1999 Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 20 3551 3567 10612281 10.1002/(SICI)1522-2683(19991201)20: 18<3551::AID-ELPS3551>3.0.CO;2-2 1:CAS:528:DC%2BD3cXhtF2ntw%3D%3D (Pubitemid 30007252)
23. JI Kreisberg SN Malik TJ Prihoda RG Bedolla DA Troyer S Kreisberg PM Ghosh 2004 Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer Cancer Res 64 5232 5236 15289328 10.1158/0008-5472.CAN-04-0272 1:CAS:528:DC%2BD2cXmtF2mtbo%3D (Pubitemid 39006542)
24. AE Finlayson KW Freeman 2009 A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis PLoS One 4 e7833 19924305 10.1371/journal.pone.0007833
25. P Lajoie JG Goetz JW Dennis IR Nabi 2009 Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane J Cell Biol 185 381 385 19398762 10.1083/jcb.200811059 1:CAS:528:DC%2BD1MXlvFSrur8%3D
26. FR Maxfield 2002 Plasma membrane microdomains Curr Opin Cell Biol 14 483 487 12383800 10.1016/S0955-0674(02)00351-4 1:CAS:528:DC%2BD38XlvFCjsL0%3D (Pubitemid 35279109)
27. MA McNiven HM Thompson 2006 Vesicle formation at the plasma membrane and trans-Golgi network: the same but different Science 313 1591 1594 16973870 10.1126/science.1118133 1:CAS:528:DC%2BD28XpsVOkurw%3D (Pubitemid 44414025)
28. J Saraste B Goud 2007 Functional symmetry of endomembranes Mol Biol Cell 18 1430 1436 17267686 10.1091/mbc.E06-10-0933 1:CAS:528:DC%2BD2sXktVSmtb0%3D (Pubitemid 46626637)
29. MF Olson A Ashworth A Hall 1995 An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1 Science 269 1270 1272 7652575 10.1126/science.7652575 1:CAS:528:DyaK2MXnvVeqtLc%3D
30. Y Wei Y Zhang U Derewenda X Liu W Minor RK Nakamoto AV Somlyo AP Somlyo ZS Derewenda 1997 Crystal structure of RhoA-GDP and its functional implications Nat Struct Biol 4 699 703 9302995 10.1038/nsb0997-699 1:CAS:528: DyaK2sXmtl2qu70%3D
31. CH Chan SW Lee CF Li J Wang WL Yang CY Wu J Wu KI Nakayama HY Kang HY Huang, et al. 2010 Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis Nat Cell Biol 12 457 467 20383141 10.1038/ncb2047 1:CAS:528:DC%2BC3cXlsFGgsrs%3D
32. D Hoshino T Tomari M Nagano N Koshikawa M Seiki 2009 A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion J Biol Chem 284 27315 27326 19654316 10.1074/jbc.M109.041400 1:CAS:528:DC%2BD1MXhtFyjsrfO
33. C Suzuki Y Daigo N Ishikawa T Kato S Hayama T Ito E Tsuchiya Y Nakamura 2005 ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway Cancer Res 65 11314 11325 16357138 10.1158/0008-5472.CAN-05-1507 1:CAS:528:DC%2BD2MXhtlWiu7%2FM (Pubitemid 41821688)
34. X Zhao L Lu N Pokhriyal H Ma L Duan S Lin N Jafari H Band V Band 2009 Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells Cancer Res 69 483 491 19147561 10.1158/0008-5472.CAN-08-2907 1:CAS:528:DC%2BD1MXltFSisQ%3D%3D